- Home
- SXTP vs SPRC Comparison
SXTP vs SPRC Comparison
Compare SXTP & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SXTP | SPRC |
|---|---|---|
| Founded | 2010 | 2004 |
| Country | United States | Israel |
| Employees | 3 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 2.5M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | SXTP | SPRC |
|---|---|---|
| Price | $1.78 | $5.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.10 | N/A |
| AVG Volume (30 Days) | ★ 233.7K | 30.5K |
| Earning Date | 05-14-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $48.39 | N/A |
| Revenue Next Year | $36.59 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.34 | $0.25 |
| 52 Week High | $8.62 | $8.90 |
Technical Indicators
Market Signals| Indicator | SXTP | SPRC |
|---|---|---|
| Relative Strength Index (RSI) | 44.76 | 70.80 |
| Support Level | $1.27 | $3.28 |
| Resistance Level | $1.95 | $6.30 |
| Average True Range (ATR) | 0.22 | 0.48 |
| MACD | 0.04 | 0.10 |
| Stochastic Oscillator | 13.50 | 58.77 |
Price Performance
Historical ComparisonAbout SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.